Applied BioCode Launches 28 Fungal Analyte-Specific Reagents
Applied BioCode has released 28 Fungal Analyte-Specific Reagents for use in molecular tests, which utilize the company’s BMB technology.
Read MorePosted by Chris Wolski | Nov 23, 2021 | Molecular Diagnostic Analyzers |
Applied BioCode has released 28 Fungal Analyte-Specific Reagents for use in molecular tests, which utilize the company’s BMB technology.
Read MorePosted by Chris Wolski | Nov 4, 2021 | Infectious Diseases |
A technique that measures the metabolic activity of bacteria with an electric probe can identify antibiotic resistance in less than 90 minutes.
Read MorePosted by Chris Wolski | Nov 2, 2021 | Covid 19 |
AMP lays the foundation for a comprehensive national testing strategy that will promote better collaboration between laboratories and test manufacturers.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Emerging & Zoonotic Diseases |
According to new research, contaminated water has been the most common driver of large-scale zoonotic infectious disease outbreaks.
Read MorePosted by Chris Wolski | Oct 20, 2021 | Diagnostic Technologies |
The NIH awarded Selux a $2.8 million grant for commercialization of its Next Generation Phenotyping platform for rapid antimicrobial susceptibility testing.
Read More